版塊導(dǎo)航: 正在加載中...

登錄注冊

應(yīng)《網(wǎng)絡(luò)安全法》要求，自2017年10月1日起，未進(jìn)行實(shí)名認(rèn)證將不得使用互聯(lián)網(wǎng)跟帖服務(wù)。為保障您的帳號能夠正常使用，請盡快對帳號進(jìn)行手機(jī)號驗(yàn)證，感謝您的理解與支持！

24小時(shí)熱門版塊排行榜

返回列表

本帖產(chǎn)生 1 個(gè) 翻譯EPI ，點(diǎn)擊這里進(jìn)行查看

deuce

金蟲 (小有名氣)

翻譯EPI: 1
應(yīng)助: 0 (幼兒園)
金幣: 1368.9
紅花: 1
帖子: 95
在線: 102.8小時(shí)
蟲號: 775134
注冊: 2009-05-20
性別: GG
專業(yè): 中藥制劑

[求助] 請幫助翻譯一段話，謝謝！

A survey of eight cancer clinical trial
centres in the UK also found that the cost
of noncommercial trials had doubled,
trials have been delayed, and staff were
demoralised in many trial centres [40].
Since funds are often collected directly
from the public by charity appeals, public
money is being spent. It always difficult to
fund clinical trials in this way, with some
of the real costs being absorbed or cross-subsidised in department accounts. Con-siderably more money is now required,
and only projects that are attractive to the
pharmaceutical industry are likely to
proceed. Since outcomes are often better
in patients taking part in clinical trials,
countless thousands receiving care outside
of trials are therefore having their health
damaged because of the reduced recruit-ment into trials. This is particularly true of
areas that are of no interest to the
pharmaceutical industry.

回復(fù)此樓

» 猜你喜歡

求調(diào)劑推薦材料 304 已經(jīng)有3人回復(fù)
336材料求調(diào)劑已經(jīng)有7人回復(fù)
材料學(xué)碩333求調(diào)劑已經(jīng)有6人回復(fù)
一志愿鄭州大學(xué)，080500學(xué)碩，總分317分求調(diào)劑已經(jīng)有5人回復(fù)
351求調(diào)劑已經(jīng)有3人回復(fù)
316求調(diào)劑已經(jīng)有3人回復(fù)
349求調(diào)劑已經(jīng)有4人回復(fù)
343求調(diào)劑已經(jīng)有3人回復(fù)
341求調(diào)劑已經(jīng)有5人回復(fù)
325求調(diào)劑已經(jīng)有4人回復(fù)

sayhi

1樓 2013-07-30 16:06:32

已閱回復(fù)此樓關(guān)注TA 給TA發(fā)消息送TA紅花 TA的回帖

etshao

銅蟲 (初入文壇)

翻譯EPI: 1
應(yīng)助: 1 (幼兒園)
金幣: 122.2
帖子: 19
在線: 18.3小時(shí)
蟲號: 2628647
注冊: 2013-09-01
性別: MM
專業(yè): 碳素材料與超硬材料

【答案】應(yīng)助回帖

★ ★ ★ ★ ★
deuce: 金幣+5, 翻譯EPI+1, ★★★★★最佳答案 2013-09-02 16:27:39

根據(jù)對英國8家抗癌臨床實(shí)驗(yàn)中心的調(diào)查同樣顯示非盈利實(shí)驗(yàn)成本翻倍，實(shí)驗(yàn)延期，多家實(shí)驗(yàn)中心的職員情緒不佳。實(shí)驗(yàn)基金通常直接源于慈善對社會(huì)的呼吁，公款也在使用中，但通常實(shí)驗(yàn)基金很難實(shí)現(xiàn)獲得某些經(jīng)費(fèi)資助或是政府部門的捐助。如今則是需要更多的資金，并且只有對醫(yī)藥行業(yè)有利益的項(xiàng)目才能得以實(shí)施。由于臨床實(shí)驗(yàn)患者的醫(yī)療效果較好，但又因招收臨床實(shí)驗(yàn)人數(shù)的減少，接受實(shí)驗(yàn)之外治療的無數(shù)人群遭受著健康受損。這種情況在對醫(yī)藥行業(yè)沒有利益的領(lǐng)域尤為明顯。

贊一下(1人)

回復(fù)此樓

2樓2013-09-02 10:20:51

已閱回復(fù)此樓關(guān)注TA 給TA發(fā)消息送TA紅花 TA的回帖

相關(guān)版塊跳轉(zhuǎn) 我要訂閱樓主 deuce 的主題更新